THE RESULTS OF CHRONOS19 STUDY IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES AND COVID-19 IN RUSSIA WERE PRESENTED AT 2021 ESMO ANNUAL MEETING
This year’s meeting of the European Society for Medical Oncology (ESMO) took place online on September 16-21. In frames of the scientific program, a poster on the treatment outcomes and antibody immunity to SARS-CoV-2 in patients with hematological malignancies was presented by CHRONOS19 investigators.
A full abstract can be found here: https://oncologypro.esmo.org/meeting-resources/esmo-congress-2021/treatment-outcomes-and-antibody-immunity-to-sars-cov-2-in-patients-with-hematological-malignancies